Regulatory functions of human CD4+ T cells recognizing allopeptides in the context of self-HLA class II

Human Immunology

Volumn 63, Issue 10, 2002, Pages 902-911

  Roelen, Dave L ^a   Van Bree, S ^a   Van Hulst, P ^a   Van Beelen, E ^a   Claas, F H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

HLA class II; Indirect allorecognition; Regulatory T cell; Transplantation

Indexed keywords

CD4 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; PEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN RECOGNITION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOFLUORESCENCE; IMMUNOREGULATION; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; AUTOANTIGENS; BLOOD TRANSFUSION; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; DOWN-REGULATION; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-10; MOLECULAR SEQUENCE DATA; TRANSPLANTATION IMMUNOLOGY;

EID: 0036775284     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00453-6     Document Type: Article

References (43)

1. Fabre JW, Morris PJ: The effect of donor strain blood pretreatment on renal allograft rejection in rats. Transplantation 14:608, 1972.
2. Opelz G, Sengar DPS, Mickey MR, Terasaki PI: Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5:253, 1973.
3. Morris PJ, Ting A, Stocker J: Leukocyte antigens in renal transplantation. The paradox of transfusions in renal transplantation. Med J Aust 2:1088, 1968.
4. Cicciarelli J: UNOS Registry data: Effect of transfusions. Clin Transpl XXX:407, 1990.
5. Opelz G, Vanrenterghem Y, Kirste G, Gray DW, Horsburgh T, Lachance JG, Largiader F, Lange H, Vujaklija-Stipanovic K, Alvarez-Grande J, Schott W, Hoyer J, Schnuelle P, Descoeudres C, Ruder H, Wujciak T, Schwarz V: Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 63:964, 1997.
6. Lagaaij EL, Hennemann IP, Ruigrok M, de Haan MW, Persijn GG, Termijtelen A, Hendricks GF, Weimar W, Claas FH, van Rood JJ: Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. New Engl J Med 321:701, 1989.
7. Lagaaij EL, Ruigrok MB, van Rood JJ, Hendriks GF, van der Woude F, Weimar W, van Houwelingen HC, Goulmy E: Blood transfusion induced changes in cell-mediated-lympholysis: To immunize or not to immunize. J Immunol 147:3348, 1991.
8. Middleton D, Martin J, Douglas J, McClelland M: Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft. Transplantation 58:845, 1994.
9. Bayle F, Masson D, Zaoui P, Vialtel P, Janbon B, Bensa JC, Cordonnier DJ: Beneficial effect of one HLA haplo- or semi-identical transfusion versus three untyped blood units on alloimmunisation and acute rejection episodes in first renal allograft recipients. Transplantation 59:719, 1995.
10. Van der Mast BJ, Balk AH: The effect of HLA-DR-shared blood transfusions on the clinical outcome of heart transplantation. Transplantation 63:1514, 1997.
11. Salvatierra O, Melzer J, Vincenti F, Amend Jr WJ, Tomlanovich S, Potter D, Husing R, Garovoy M, Feduska NJ: Donor-specific blood transfusions versus cyclosporine-the DST story. Transplant Proc 19:160, 1987.
12. Burlingham WJ, Grailer AP, Fechner JH, Kusaka S, Trucco M, Kocova M, Belzer FO, Sollinger HW: Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation 59:1147, 1995.
13. van Rood JJ, Claas FHJ: The influence of allogeneic cells on the human T and B cell repertoire. Science 248:1388, 1990.
14. Sherwood RA, Brent L, Rayfield LS: Presentation of alloantigens by host cells. Eur J Immunol 16:569, 1986.
15. De Koster HS, Anderson DC, Termijtelen A: T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J Exp Med 169:1191, 1989.
16. Chen BP, Madrigal A, Parham P: Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule. J Exp Med 172:779, 1990.
17. Liu Z, Braunstein NS, Suciu-Foca N: T cell recognition of allopeptides in context of syngeneic MHC. J Immunol 148:35, 1992.
18. Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE: Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 175:305, 1992.
19. Parker K, Dalchau R, Fowler V, Priestley C, Carter C, Fabre J: Stimulation of CD4+ T lymphocytes by allogeneic MHC peptides presented on autologous antigen-presenting cells. Evidence of the indirect pathway of allorecognition in some strain combinations. Transplantation 53:918, 1992.
20. Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss HJ: Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med 179:865, 1994.
21. Ottenhof TH, Mutis T: Specific killing of cytotoxic T cells and antigen presenting cells by CD4+ cytotoxic T cell clones. J Exp Med 171:2011, 1990.
22. Pichler WJ, Wyss-Coray T: T cells as antigen-presenting cells. Immunol Today 15:312, 1994.
23. Frasca L, Amendola A, Hornick P, Brookes P, Aichinger G, Marelli-Berg F, Lechler RI, Lombardi G: Role of donor and recipient antigen-presenting cells in priming and maintaining T cells with indirect allospecificity. Transplantation 66:1238, 1998.
24. Zhang L, Li SG, Vandekerckhove B, Termijtelen A, van Rood JJ, Claas FH: Analysis of cytotoxic T cell precursor frequencies directed against individual HLA-A and -B alloantigens. J Immunol Methods 121:39, 1989.
25. Roelen DL, Dover EL, Niimi M, Young NT, Morris PJ, Wood KJ: Semi-allogeneic (F1) versus fully allogeneic blood transfusions: Differences in their ability to induce specific immunological unresponsiveness. Eur J Immunol 26:1468, 1996.
26. Roelen DL, Niimi M, Witzke O, van Rood JJ, Claas FHJ, Wood KJ: The importance of H-2 haplotype sharing in the induction of specific unresponsiveness by pre-transplant blood transfusions. Transplantation 69:411, 2000.
27. Roelen DL, Bushell AR, Niimi M, Young NT, Rust NA, Morris PJ, Wood KJ: Immunoregulation by CD4 T cells in the induction of specific immunological unresponsiveness to alloantigens in vivo: Evidence for a reduction in the frequency of alloantigen-specific cytotoxic T cells in vitro. Hum Immunol 59:529, 1998.
28. Suciu-Foca N, Harris PE, Cortesini R: Intramolecular and intermolecular spreading during the course of organ allograft rejection. Immunol Rev 164:241, 1998.
29. Tugulea S, Ciubotariu R, Colovai AI, Liu Z, Itescu S, Schulman LL, Fisher PE, Hardy MA, Rose EA, Michler RE, Cortesini R, Suciu-Foca N: New strategies for early diagnosis of heart allograft rejection. Transplantation 64:842, 1997.
30. Siliciano RF, Lawton T, Knall C, Karr RW, Berman P, Gregory T, Reinherz E: Analysis of host virus interactions in AIDS with anti gp120 T cell clones: Effect of HIV sequence variation and a mechanism for CD4+ cell depletion. Cell 54:561, 1988.
31. Eljaafari A, Dorval I, Zeliszewski D, Le Gac S, Sterkers G: Requirements for lysis of activated T cells by class II-restricted cytolytic T lymphocytes. Hum Immunol 35:50, 1992.
32. Susskind B, Iannotti MR, Shornick MD, Steward NS, Gorka J, Mohanakumar T: Indirect allorecognition of HLA class I peptides by CD4+ cytolytic T lymphocytes. Hum Immunol 46:1, 1996.
33. Pointdexter NJ, Smith MA, Haynes AE, Mohanakumar T: Regulatory function of human CD4+ cytolytic T lymphocytes. Transplant Immunol 7:45, 1999.
34. Piazza C, Gilardini Montani MS, Moretti S, Cundari E, Piccolella E: CD4+ T cells kill CD8+ T cells via Fas/Fas ligand-mediated apoptosis. J Immunol 158:1503, 1997.
35. Lanzavecchia A, Roosnek E, Gregory T, Berman P, Abrignani S: T cells can present antigens such as HIV gp120 targeted to their own surface molecules. Nature 334:530, 1988.
36. Hewett CRA, Feldman M: Human T cell clones present antigen. J Immunol 142:1429, 1989.
37. Del Prete GF, De Carli M, Almerigogna F, Giudizi MG, Bagiotti R, Romagnani S: Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. J Immunol 150:353, 1993.
38. Buelens C, Willems F, Pierard G, Delvaux A, Velu T, Goldman M: IL-10 inhibits the primary allogeneic T cell response to human peripheral blood dendritic cells. Adv Exp Med Biol 378:363, 1995.
39. Thomson AW, Lu L: Dendritic cells as regulators of immune reactivity: Implications for transplantation. Transplantation 68:1, 1999.
40. Steinbrink K, Wölfl M, Jonuleit H, Knop J, Enk AH: Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159:4772, 1997.
41. Li W, Fu F, Lu L, Narula SK, Fung JJ, Thomson AW, Qian S: Differential effects of exogenous interleukin-10 on cardiac allograft survival: Inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function. Transplantation 68:1402, 1999.
42. Liu Z, Tugulea S, Cortesini R, Lederman S, Suciu-Foca N: Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells. Hum Immunol 60:568, 1999.
43. Levings MK, Sangregorio R, Roncarolo MG: Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193:1295, 2001.